Premium
Prognostic value of the 131 I whole‐body scan in postsurgical therapy for differentiated thyroid cancer
Author(s) -
Pupi Alberto,
Castagnoli Antonio,
Morotti Aldo,
La Cava Giuseppe,
Meldolesi Ugo
Publication year - 1983
Publication title -
cancer
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.052
H-Index - 304
eISSN - 1097-0142
pISSN - 0008-543X
DOI - 10.1002/1097-0142(19830801)52:3<439::aid-cncr2820520309>3.0.co;2-n
Subject(s) - medicine , thyroid cancer , cancer , value (mathematics) , thyroid , whole body imaging , oncology , radiology , magnetic resonance imaging , statistics , mathematics
Seventy‐two patients affected by differentiated thyroid cancer underwent whole‐body scan seven days after the postsurgical thyroablative treatment with 131 I. In 40 patients this scanning did not reveal any area of 131 I uptake outside the residual thyroid parenchyma. During the follow‐up period, no signs of functioning tumors were detected in these patients and therefore, there was no need for further therapeutic treatment with radioiodine. From this results it is legitimate to conclude that whole‐body scan control can be significantly postponed without diagnostic inaccuracy for those patiants whose postthyroablative scans do not reveal diffuse tumor localizations.